Judge Overturns Purdue Pharma’s Opioid Settlement
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from […]
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
The payout to New York will take place over the next 17 years, and joins a $26 billion deal to settle the thousands of nationwide […]
Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler […]
In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that […]
Copyright © 2024 | WordPress Theme by MH Themes